Invest for a Sustainable Future, Impact Capital Asset Management

ICAM

Invest for a Sustainable Future

Impact Capital Asset Management

Established in August 2020, Impact Capital Asset Management Pte. Ltd. (ICAM) was conceived by seasoned professionals Deepak Mawandia and Atul Tetambe. Both have accumulated a wealth of knowledge and experience from their extensive tenures in the financial sector. In 2019, ICAM secured its RFMC license and subsequently introduced a technology-centric venture fund. By 2021, with the acquisition of its CMS license, ICAM witnessed steady growth in its assets under management. Presently, ICAM manages a portfolio exceeding USD 1 billion, diversified across various countries. Central to ICAM’s foundation is a commitment to offering a platform singularly dedicated to the best interests of its investor clients. The combined expertise of Deepak and Atul firmly establishes ICAM as a notable entity in the wealth management field.

Equity Bottom-Up

<ul><li>Thomson has a meaningful regional healthcare platform across Singapore, Malaysia and Vietnam.</li><li>FY2025 revenue was S$394.7m, up from S$240.4m in FY2021, with Singapore contributing S$190.4m, Malaysia S$105.8m and Vietnam S$98.5m.</li><li>The group has 820 licensed beds across the three markets, plus clinics, fertility centres, diagnostics and specialist services. </li></ul>

Thomson has a meaningful regional healthcare platform across Singapore, Malaysia and Vietnam.FY2025 revenue was S$394.7m, up from S$240.4m in FY2021, with Singapore contributing S$190.4m, Malaysia S$105.8m and Vietnam S$98.5m.The group has 820 licensed beds across the three markets, plus clinics, fertility centres, diagnostics and specialist services. 

Thomson Medical Group Limited Initiating Coverage

Multi-Family Office & Asset Management, Phidelis Capital

Phidelis Capital

Multi-Family Office & Asset Management

A buy side firm - a multi-family office & an asset management firm - regulated by the Monetary Authority of Singapore (MAS), holding a Capital Markets Services (CMS) License under the Securities & Futures Act 2001

Thematic (Sector/Industry)

<ul><li>Phidelis Capital's inaugural Phidelis360 report assesses five SGX-listed mid-cap healthcare companies</li><li>Tianjin Pharma, Haw Par Corp, Raffles Medical Group, Thomson Medical Group, and Riverstone Holdings</li><li>Shortlisted from over thirty SGX-listed small- and mid-cap healthcare stocks, across operating and financial performance, ESG assessments, and analysts coverage.</li></ul>

Phidelis Capital's inaugural Phidelis360 report assesses five SGX-listed mid-cap healthcare companiesTianjin Pharma, Haw Par Corp, Raffles Medical Group, Thomson Medical Group, and Riverstone HoldingsShortlisted from over thirty SGX-listed small- and mid-cap healthcare stocks, across operating and financial performance, ESG assessments, and analysts coverage.

Assessing SGX-Listed Healthcare Companies’ Financial & ESG Performance

Singapore

Thomson Medical Group is a Singapore-headquartered healthcare services provider specializing in women's and children's healthcare, operating hospitals, specialist clinics, and healthcare facilities. Its services include obstetrics, gynaecology, fertility treatment, paediatrics, diagnostic imaging, and traditional Chinese medicine. The company was established in 1979 and is headquartered in Singapore.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Thomson Medical Group (TMG SP)

Thomson Medical Group Limited Initiating Coverage

Thomson has a meaningful regional healthcare platform across Singapore, Malaysia and Vietnam. FY2025 revenue was S$394.7m, up from S$240.4m in...

ICAM

Assessing SGX-Listed Healthcare Companies’ Financial & ESG Performance

Phidelis Capital's inaugural Phidelis360 report assesses five SGX-listed mid-cap healthcare companies Tianjin Pharma, Haw Par Corp, Raffles...

Phidelis Capital

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)